Intellia Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$15.67

+0.47 (+3.09%)

As of Jun 21, 10:08 PM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 15 54%

Hold 11 39%

Sell 2 7%

Price Target

Analyst Price Target +107.5% upside

Low Target $20.88

Average Target $32.51

High Target $45.64

Current Price $15.67

Current
$15.67

Target
$32.51

$20.88 $32.51 avg $45.64

Scenario Analysis

Bear Case

$20.88

33.2%

Low target

Base Case

$32.51

+107.5%

Avg target

Bull Case

$45.64

+191.3%

High target

Risk/Reward

5.8x

Highly favorable

Price in Context

52-Week High

$28.25

-44.5% from high

52-Week Low

$7.95

+97.1% from low

Target vs 52W High

$32.51

+15.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%